# Xiaoming Xie

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiaoming-xie/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,057 |
| Field | Breast Cancer Treatment Studies |
| h-index | 33 |
| i10-index | 43 |
| Last Known Institution | Sun Yat-sen University |
| OpenAlex ID | https://openalex.org/A5109402835 |
| Works | 67 |

## Researcher papers

- [Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling](https://scholariq.org/papers/quercetin-suppresses-cyclooxygenase-2-expression-and-angiogenesis-through/)
- [A novel axis of circKIF4A-miR-637-STAT3 promotes brain metastasis in triple-negative breast cancer](https://scholariq.org/papers/a-novel-axis-of-circkif4a-mir-637-stat3-promotes-brain-metastasis-in-triple/)
- [Genome-Wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer](https://scholariq.org/papers/genome-wide-association-study-in-east-asians-identifies-novel-susceptibility/)
- [Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer](https://scholariq.org/papers/methylation-of-gprc5a-promotes-liver-metastasis-and-docetaxel-resistance-through/)
- [LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer](https://scholariq.org/papers/linc01638-lncrna-activates-mtdh-twist1-signaling-by-preventing-spop-mediated-c/)
- [Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer](https://scholariq.org/papers/linc00152-promotes-tumorigenesis-by-regulating-dnmts-in-triple-negative-breast/)
- [Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis](https://scholariq.org/papers/discordance-of-immunotherapy-response-predictive-biomarkers-between-primary/)
- [crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer](https://scholariq.org/papers/crvdac3-alleviates-ferroptosis-by-impeding-hspb1-ubiquitination-and-confers/)
- [Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12](https://scholariq.org/papers/regression-of-colon-cancer-and-induction-of-antitumor-immunity-by-intratumoral/)
- [Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancer](https://scholariq.org/papers/identification-and-validation-of-a-combined-hypoxia-and-immune-index-for-triple/)
- [Second invasive breast cancers in patients treated with breast-conserving therapy](https://scholariq.org/papers/second-invasive-breast-cancers-in-patients-treated-with-breast-conserving/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

## Researcher university

- [Sun Yat-sen University](https://scholariq.org/institutions/sun-yat-sen-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.